News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CISBIO Adopts BellBrook Labs' Transcreener Platform for Enhanced Target Screening Services


11/15/2007 12:12:57 PM

MADISON, Wis.--(BUSINESS WIRE)--BellBrook Labs, a leading provider of high throughput screening tools for the drug discovery industry, today announced that Cisbio, a global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, is adopting BellBrook's Transcreener™ HTS Assay Platform as part of a technology licensing agreement.

Read at BioSpace.com


comments powered by Disqus
CISBIO
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES